News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
BROWN MORGAN R
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/03/2023 |
4
| BROWN MORGAN R (CFO) has filed a Form 4 on Clene Inc.
Txns:
| Granted 400,000 options to buy
@ $0.9, valued at
$360k
|
|
11/07/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/03/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
02/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/08/2021 |
4
| BROWN MORGAN R (CFO) has filed a Form 4 on Lipocine Inc.
Txns:
| Granted 176,000 options to buy
@ $1.12, valued at
$197.1k
|
|
12/17/2020 |
4
| BROWN MORGAN R (EVP and CFO) has filed a Form 4 on Lipocine Inc.
Txns:
| Sold 8,437 shares
@ $1.35, valued at
$11.4k
Granted 160,000 options to buy
@ $1.37, valued at
$219.2k
Exercised 28,125 restricted stock units
@ $0 |
|
12/08/2020 |
4
| BROWN MORGAN R (CFO) has filed a Form 4 on Lipocine Inc.
Txns:
| Sold 17,250 shares
@ $1.5666, valued at
$27k
Exercised 57,500 restricted stock units
@ $0 Exercised 70,754 restricted stock units
@ $0 |
|
01/28/2020 |
4
| BROWN MORGAN R (EVP and CFO) has filed a Form 4 on Lipocine Inc.
Txns:
| Granted 132,000 options to buy
@ $0.458, valued at
$60.5k
|
|
12/06/2019 |
4
| BROWN MORGAN R (EVP and Chief Financial Office) has filed a Form 4 on Lipocine Inc.
Txns:
| Sold 17,250 shares
@ $0.4102, valued at
$7.1k
Exercised 57,500 restricted stock units
@ $0 Granted 70,754 restricted stock units
@ $0 |
|
12/06/2018 |
4
| BROWN MORGAN R (EVP and CFO) has filed a Form 4 on Lipocine Inc.
Txns:
| Granted 115,000 restricted stock units
@ $0 Granted 75,000 options to buy
@ $1.46, valued at
$109.5k
|
|
01/02/2018 |
4
| BROWN MORGAN R (EVP and CFO) has filed a Form 4 on Lipocine Inc.
Txns:
| Sold 2,813 shares
@ $3.4744, valued at
$9.8k
Exercised 9,375 restricted stock units
@ $0 |
|
12/06/2017 |
4
| BROWN MORGAN R (EVP and CFO) has filed a Form 4 on Lipocine Inc.
Txns:
| Granted 75,000 options to buy
@ $3.52, valued at
$264k
|
|
01/30/2017 |
4
| BROWN MORGAN R (EVP and CFO) has filed a Form 4 on Lipocine Inc. |
12/08/2016 |
4
| BROWN MORGAN R (EVP and CFO) has filed a Form 4 on Lipocine Inc. |
01/07/2016 |
4
| BROWN MORGAN R (Executive Vice President/CFO) has filed a Form 4 on Lipocine Inc.
Txns:
| Granted 50,000 options to buy
@ $12.92, valued at
$646k
|
|
08/15/2014 |
4
| BROWN MORGAN R (Executive Vice President) has filed a Form 4 on Lipocine Inc.
Txns:
| Granted 34,268 options to buy
@ $8.43, valued at
$288.9k
|
|
12/11/2013 |
4
| BROWN MORGAN R (EVP and CFO) has filed a Form 4 on Lipocine Inc.
Txns:
| Granted 15,000 options to buy
@ $8.1, valued at
$121.5k
Granted 5,000 restricted stock units
@ $1, valued at
$5k
|
|
09/18/2013 |
4
| BROWN MORGAN R (EVP and CFO) has filed a Form 4 on Lipocine Inc.
Txns:
| Granted 12,000 shares
@ $0 Granted 50,000 options to buy
@ $6, valued at
$300k
|
|
06/28/2013 |
4/A
| BROWN MORGAN R (See remarks) has filed a Form 4 on INNOVUS PHARMACEUTICALS, INC.
Txns:
| Granted 750,000 shares
@ $0 |
|
05/30/2013 |
4
| BROWN MORGAN R (See remarks) has filed a Form 4 on INNOVUS PHARMACEUTICALS, INC.
Txns:
| Granted 750,000 shares
@ $0 |
|
09/06/2011 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
06/30/2011 |
4
| BROWN MORGAN R (Exec. VP and CFO) has filed a Form 4 on WORLD HEART CORP
Txns:
| Granted 51,000 options to buy
@ $0.99, valued at
$50.5k
|
|
02/15/2011 |
4
| BROWN MORGAN R (Exec. VP and CFO) has filed a Form 4 on WORLD HEART CORP
Txns:
| Granted 25,000 options to buy
@ $1.65, valued at
$41.3k
|
|
09/09/2010 |
4/A
| Form 4 - Statement of changes in beneficial ownership of securities [amend] |
09/03/2010 |
4
| BROWN MORGAN R (Exec. VP and CFO) has filed a Form 4 on WORLD HEART CORP |
02/08/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
08/11/2009 |
4
| BROWN MORGAN R (Exec. VP and CFO) has filed a Form 4 on WORLD HEART CORP |
08/11/2009 |
3
| Form 3 -- Initial statement of beneficial ownership of securities |
|
|